Announced Tue, 18 Aug · 12:23 IST
Credit rating upgraded to IND A with Positive Outlook by Ind-Ra
ONESOURCE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-1.9%1-day move
₹1545.00
prior close
₹1550.60
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.2+0.1+0.1-0.6-1.9-0.6-0.8———————
Up moveDown movePending
AI summary
India Ratings upgraded OneSource Specialty Pharma long-term bank loan rating from IND A- to IND A with Positive Outlook. Short-term rating affirmed at IND A1. Upgrade covers about Rs 1,125 crore existing facilities and Rs 429 crore newly assigned limits. Driven by successful drug-device combination platform commercialisation and rising GLP-1 supplies.
Likely market impact
Rating upgrade reflects strengthening credit profile and business. Lower borrowing costs likely, positive lender sentiment. Positive Outlook signals possible further upgrade.